mirvetuximab
immunogen
['ovarian', '$imgn']
another impressive result this morning. $imgn's elahere prolongs survival in advanced ovarian cancer by three months, or 33%. #asco23 by .
Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @matthewherper@federate.social